NCT05079009View on ClinicalTrials.gov

Effects of Blood Pulsatility on Von Willebrand Factor During ECCO2R

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 28, 2022

Primary Completion Date

May 16, 2023

Study Completion Date

May 16, 2023

Conditions
Extracorporeal CO2 RemovalAcute Respiratory Distress SyndromeChronic Obstructive Pulmonary Disease ExacerbationPulmonary Disease
Interventions
DEVICE

ECCO2R pulsatile configuration

Use of the pulsatile extracorporeal blood flow configuration.

Trial Locations (1)

75015

Hôpital européen Georges Pompidou, Paris

All Listed Sponsors
collaborator

Xenios AG

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER